Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 MALATTIA NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Pathogenic mechanisms -
--->News
[-]Il Progetto
--->Sponsor
--->[+]Executive Committee
--->[+]Writing Committee Strategic ...
--->[+]Scientific and Bioethics Advis...
--->Central Coordination
--->Language Coordination
--->Fellowship Programme
--->[-]Constitution
--->Article 1
--->Article 2
--->Article 3
--->Article 4
--->Article 5
--->Article 6
--->Article 7
--->Article 8
--->Article 9
--->Article 10
--->Article 11
--->Article 12
--->Documents
--->[+]Voting/Nomination
--->[-]Members
--->Request
[+]Località
[-]Gruppi di lavoro
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[+]Young Adults
[-]Events
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Final Programme
--->Plenary Dinner
--->Registration
--->Working Groups
--->Meeting Venue
--->Manchester
--->Evaluation & Feedback
--->[+]EHDN 2004
[+]Comunicazioni
--->Offerte di lavoro
datadescrizionesizeautore documento 
04.08.26A framework for cross-species data integration, model sensitivity analysis and target prioritisation in Huntington’s disease using bionetworks32 kBanonymousapplication/mswordb01-framework-cross-species-data-integ... 
04.08.26Huntington’s disease and its therapeutic target genes: a global functional profile based on the HD research crossroads database32 kBanonymousapplication/mswordb02-huntington’s-disease-and-its-thera... 
04.08.26HDAC4 interacts with Huntingtin and HDAC4 reduction decreases cytoplamsic aggregation and rescues synaptic dysfunction in HD mouse models32 kBanonymousapplication/mswordb11-hdac4-interacts-with-huntingtin 
04.08.26The role of N-terminal phosphorylation in Huntingtin´s oligomerization, aggregation and toxicity32 kBanonymousapplication/mswordb10-n-terminal-phosphorylation 
04.08.26Long-term alterations in dendritic spine stability in Huntington Disease: Mechanisms underlying learning deficits in Huntington Disease?32 kBanonymousapplication/mswordb12-mechanisms-underlying-learning-def... 
04.08.26CTCF in Huntington’s Disease32 kBanonymousapplication/mswordb16-ctcf-in-hd 
04.08.26Caspase-6 does not contribute to the proteolysis of mutant Huntingtin in the HDHQ150 knock-in mouse model of Huntington's Disease32 kBanonymousapplication/mswordb09-caspase-6 
04.08.26Huntingtin mediates anxiety/depression-related behaviors in mouse through BDNF transport and hippocampal neurogenesis32 kBanonymousapplication/mswordb15-bdnf-transport-hippocampal-neuroge... 
04.08.26Analysis of Huntingtin protein fragments in post mortem human Huntington's Disease brain tissue32 kBanonymousapplication/mswordb07-protein-fragments-post-mortem-human 
04.08.26AMPK activation alleviates phenotypes associated to the early phases of mutant polyQ cytoxicity32 kBanonymousapplication/mswordb04-ampk-activation 
04.08.26Systematic interactome mapping: understanding the molecular principles of neurodegenerative diseases32 kBanonymousapplication/mswordb03-systematic-interactome-mapping 
04.08.26CAG profiling in R6/1 89Q indicates early and progressive expansion in critical neuronal populations and expansion and changes in surrounding glial cell populations32 kBanonymousapplication/mswordb05-cag-profiling-in-r61-89q 
04.08.26Genotoxic stress in fibroblasts and mesenchymal stem cells isolated from miniature pigs transgenic for n-terminal part of mutated human huntingtin32 kBanonymousapplication/mswordb06-genotoxic-stress-fibroblasts-mesen... 
04.08.26Collapsin response mediator protein 4 downregulates aggregation and toxicity of mutant huntingtin32 kBanonymousapplication/mswordb17-collapsin-response-mediator-protei... 
04.08.26Differential sensitivity of aggregate markers in HdhQ150 and YAC128 HD mouse models32 kBanonymousapplication/mswordb08-differential-sensitivity-of-aggreg... 
04.08.26Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation32 kBanonymousapplication/mswordb18-delaying-aging-and-aging-associate... 
04.08.26Does a peripheral immune response influence muscle pathology in Huntington’s Disease?32 kBanonymousapplication/mswordb23-peripheral-immune-response-muscle-... 
04.08.26Immune dysfunction in HD human myeloid cells is caused by NFkB pathway dysregulation and is reversed by lowering HTT levels32 kBanonymousapplication/mswordb24-immune-dysfunction-in-hd-human-mye... 
04.08.26Hyperdopaminergic status in Huntington's Disease32 kBanonymousapplication/mswordb26-hyperdopaminergic-status-in-hd 
04.08.26Decreased expression and reduced translocation to the sarcolemma of the insulin-sensitive glucose transporter GLUT4 in skeletal muscle of R6/2 mice32 kBanonymousapplication/mswordb22--reduced-translocation-sarcolemma 
04.08.26Dysfunctional dopaminergic neurones and biphasic activitydependent dopamine release in mouse models of Huntington’s Disease32 kBanonymousapplication/mswordb25-dysfunctional-dopaminergic-neurone... 
04.08.26Glucose metabolism is reduced in Huntington Disease: in-vivo and in-vitro evidence32 kBanonymousapplication/mswordb19-glucose-metabolism 
04.08.26Lactate metabolism in the Huntington's Disease mouse model R6/232 kBanonymousapplication/mswordb20-lactate-metabolism 
04.08.26Increased glucose uptake in white adipose tissue of R6/2 mice due to changes in expression and translocation of glucose transporter 4 (GLUT4)32 kBanonymousapplication/mswordb21-increased-glucose-uptake-white-adi... 
04.08.26Deletion of mutant Huntingtin expression in Sim1 neurons in the BACHD mouse model of Huntington's Disease32 kBanonymousapplication/mswordb32-deletion-of-mutant-huntingtin-expr... 
04.08.26Copy number variation of the neuronal glucose transporter 3 and age of onset in Huntington’s Disease32 kBanonymousapplication/mswordb0x-neuronal-glucose-transporter-3 
04.08.26Expression of mutant Huntingtin in leptin receptorexpressing neurons does not influence the metabolic phenotype and psychiatric-like features in Huntington’s Disease32 kBanonymousapplication/mswordb31-expression-of-mutant-huntingtin-le... 
04.08.26Sleep and EEG abnormalities in Huntington’s Disease mice32 kBanonymousapplication/mswordb27-sleep-and-eeg-abnormalities 
04.08.26Components of the translational machinery modify toxicity in models of Huntington’s Disease32 kBanonymousapplication/mswordb0y-translational-machinery-modify-tox... 
04.08.26Neural mechanisms underlying the dysfunction of the methamphetamine-sensitive circadian oscillator (MASCO) in a mouse model of Huntington’s Disease32 kBanonymousapplication/mswordb29-neural-mechanisms-dysfunction-masco 
04.08.26Voluntary exercise improves circadian function in a mouse model of Huntington’s Disease32 kBanonymousapplication/mswordb30-circadian-function-in-mouse-model 

Folder contiene 31 documents.
about us | privacy statement | disclaimer | terms of use